Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q26853183)
Watch
English
Treatment of inflammatory bowel disease (IBD)
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
PubMed
review article
1 reference
stated in
Europe PubMed Central
title
Treatment of inflammatory bowel disease (IBD)
(English)
1 reference
stated in
PubMed
main subject
inflammatory bowel diseases
0 references
inflammation
0 references
author name string
Pithadia AB
series ordinal
1
1 reference
stated in
PubMed
Jain S
series ordinal
2
1 reference
stated in
PubMed
language of work or name
English
1 reference
stated in
PubMed
publication date
2011
1 reference
stated in
PubMed
published in
Pharmacological Reports
1 reference
stated in
PubMed
volume
63
1 reference
stated in
PubMed
issue
3
1 reference
stated in
PubMed
page(s)
629-42
1 reference
stated in
PubMed
cites work
Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preliminary study of ciprofloxacin in active Crohn's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Protective effects of M40403, a superoxide dismutase mimetic, in a rodent model of colitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: a randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inflammatory bowel disease: etiology and pathogenesis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oxidants and free radicals in inflammatory bowel disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A pilot trial of Saccharomyces boulardii in ulcerative colitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nature and course of pancreatitis caused by 6-mercaptopurine in the treatment of inflammatory bowel disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Medical therapy of inflammatory bowel disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Probiotic effects of Lactobacillus casei on DSS-induced ulcerative colitis in mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oral Budesonide in the Management of Crohn's Disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Probiotics (VSL#3) in arthralgia in patients with ulcerative colitis and Crohn's disease: a pilot study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease: an in vitro study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anti-inflammatory effects of aloe vera gel in human colorectal mucosa in vitro
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclosporine in severe ulcerative colitis refractory to steroid therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mucosal bacteria in ulcerative colitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of fish oil enriched enteral diet on inflammatory bowel disease tissues in organ culture: differential effects on ulcerative colitis and Crohn's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A double-blind, randomized, placebo-controlled trial of essential fatty acid supplementation in the maintenance of remission of ulcerative colitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Infliximab for the treatment of fistulas in patients with Crohn's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Certolizumab pegol for the treatment of Crohn's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Infliximab maintenance therapy for fistulizing Crohn's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Double blind, placebo controlled trial of metronidazole in Crohn's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of cytokine-induced nitric oxide synthase expression by gene transfer of adenoviral I kappa B alpha
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Steroid-related osteonecrosis in inflammatory bowel disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1734-1140%2811%2970575-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1734-1140(11)70575-8
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
1902833
OpenCitations bibliographic resource ID
1902833
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
1902833
PubMed ID
21857074
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
1902833
ResearchGate publication ID
51585989
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit